ArticleFrontiers in oncology2026
Differential infiltration of CD4+ and CD8+ T cells and expression of PD-L1 in paired biopsy and resection specimens of gastric and colorectal adenocarcinomas.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare CD4+ T cell, CD8+ T cell infiltration and PD-L1 expression between paired biopsy and resection specimens in gastric and colorectal adenocarcinoma, and evaluate their clinical significance. Methods: Paired biopsy and resection specimens from 38 gastric and 40 colorectal adenocarcinoma patients were assessed by immunohistochemistry for CD4+ T cell, CD8+ T cell density and PD-L1 expression. Correlations with clinicopathological parameters and tumor markers were analyzed. Results: In gastric adenocarcinoma, resection specimens showed significantly higher CD4+ T cell, CD8+ T cell density and PD-L1 expression than biopsies (all P<0.05), with CD4+ T cells positively correlated with CA19-9 (R = 0.523, P = 0.026). In colorectal adenocarcinoma, CD8+ T cell density was higher in resection specimens (P = 0.0353); CD4+ T cells negatively correlated with Ki-67 (R=-0.370, P = 0.019), and CD4+/CD8+ ratio negatively correlated with mismatch repair protein expression (R=-0.342, P = 0.029). In both cancers, CD4+/CD8+ ratios at tumor center and invasive margin were positively correlated (gastric: R = 0.5683, P = 0.0002; colorectal: R = 0.7324, P<0.0001). Preoperative neutrophil-to-lymphocyte ratio positively correlated with tumor diameter in both cancers (gastric: R = 0.449, P = 0.011; colorectal: R = 0.631, P = 0.001). CD4+ T cell density differed significantly between cancer types (P <0.0001). ROC analysis demonstrated limited predictive value of biopsy specimens for surgical findings, particularly in colorectal cancer (AUC 0.5-0.7). Conclusion: Biopsy specimens inadequately represent the immune microenvironment of resection specimens, especially in gastric adenocarcinoma. Tumor-type-specific immune assessment of biopsies is essential for guiding precise immunotherapy decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.